I'm extremely honored to be included in this accomplished list of ophthalmologists and to be seen by The Ophthalmology readers as one of the innovators in the field
GARDEN CITY, N.Y. (PRWEB) April 25, 2018
Recognizing the most influential people around the globe in ophthalmology, The Ophthalmologist, an internationally recognized magazine, named Eric Donnenfeld, MD, of Ophthalmic Consultants of Long Island (OCLI) and Ophthalmic Consultants of Connecticut (OCC) to its third annual Power List 2018 naming the Top 100 most influential people in the world of ophthalmology.
The Power List, which publishes each April, is an international celebration of ophthalmology's thought leaders and inspirational talents, and this year focuses on the most influential people in the world of ophthalmology. More than 36,000 readers across Europe and North America vote for their peers for inclusion in this annual list. Receiving this accolade is acknowledgment by his contemporaries that Dr. Donnenfeld’s contributions to the advancements in ophthalmology are only expected to grow in influence over the next decade.
"I'm extremely honored to be included in this accomplished list of ophthalmologists and to be seen by The Ophthalmology readers as one of the innovators in the field" said Donnenfeld.
“I enjoy changing the way ophthalmology is practiced. Ophthalmic Consultants of Long Island and Connecticut has recently partnered with Blue Sea Capital, a premier private equity company, to form Spectrum Vision Partners to help grow our practice to provide the highest quality of ophthalmic care throughout the New York metropolitan region. Our goal is to integrate the newest technology, surgical procedures and outcomes analysis to grow our group while providing the absolute best in patient care.”
During his nearly 30-year career, Dr. Donnenfeld has lectured and taught around the world, and has made significant advancements in the field; he was the first surgeon in the northeast US to perform laser cataract surgery, participated in the studies that led to FDA approval of the excimer laser technology. His other accomplishments include:
- Clinical Professor of Ophthalmology NYU
- Current Editor-in-Chief of EyeWorld and has written over 190 peer-reviewed papers on cornea, external disease, cataract and refractive surgery, and 30 book chapters and books.
- Participates on the editorial board of 9 journals and has participated in over 60 FDA studies.
- A primary investigator of both the excimer laser and femtosecond laser for cataract surgery.
- Fellow of the American Academy of Ophthalmology and has received its Honor Award, Senior Honor Award, Life Time Achievement Award, and Secretariat Award.
Dr. Donnenfeld practices in OCLI’s Garden City location and OCC’s Fairfield location.
About Ophthalmic Consultants of Long Island
Founded in 1997, Ophthalmic Consultants of Long Island (http://www.ocli.net) is one of the leading ophthalmology practices in the United States. OCLI boasts 15 state-of-the-art medical facilities across Nassau and Suffolk counties, housing the most advanced technology available to offer patients a variety of ophthalmic services and treatments. OCLI is led by 33 highly skilled eye surgeons in each major sub-specialty of eye care, providing comprehensive eye care services, including treatment for cataracts, corneal disease, refractive surgery, glaucoma, oculoplastics, retinal disease, neuro ophthalmology and optometry.
About Ophthalmic Consultants of Connecticut
Ophthalmic Consultants of Connecticut (http://www.occeye.com) is one of the leading combined ophthalmology/optometry practices in Connecticut. OCC boasts 4 state-of-the-art medical facilities across Connecticut, housing the most advanced technology available to offer patients a variety of ophthalmic services and treatments. OCC is led by 3 highly skilled eye surgeons as well as 3 residency trained optometrists specializing in providing comprehensive eye care services, including treatment for cataracts, corneal disease, refractive surgery, and glaucoma.
About Spectrum Vision Partners
Spectrum Vision Partners is a leading management services organization serving the ophthalmology sector. Spectrum Vision Partners has over 650 employees providing world-class practice management solutions to a network of nationally renowned multi-specialty ophthalmologists in the Tri-State region. Spectrum Vision Partners provides a comprehensive set of business support functions, including billing and collections, marketing, financial and accounting services, benefits and payroll management and information technology.
About Blue Sea Capital
Blue Sea Capital (http://www.blueseacapital.com) is a private equity firm based in West Palm Beach, Florida, that invests in growth-oriented lower middle market companies valued up to $200 million. The firm has $327 million in assets under management and invests across three industry verticals: aerospace & defense, healthcare and industrial growth. Blue Sea Capital’s strategy is to partner with talented managers and differentiated companies, typically as the first or second institutional investor, and deliver strategic and operational value-add that drives growth acceleration, industry outperformance and business transformation.